
PKD
News & Events
-
January 19, 2021
C-Path’s PKDOC Presentation on Fluid-Based Biomarkers
Critical Path Institute’s John-Michael Sauer, Ph.D. presents information on fluid-based biomarkers and how they can be applied to help advance polycystic kidney disease drug development for patients across the globe. C-Path’s Polycystic Kidney Disease Outcomes Consortium investigates tools and promotes research that will lead to the development and regulatory approval of new therapies for PKD. Watch now: https://youtu.be/4OXEMYXpOvI... - July 14, 2016